In developing countries, injections are frequently used to treat common ailments. Intramuscular injections (IMI) may damage peripheral nerves at the site of injection. Our objectives were to study the clinical features, neurophysiological findings, and outcome in patients with nerve injuries (NI) following IMI and to determine the factors affecting prognosis. We conducted a retrospective review of patients with NI following IMI, who were referred to our Neurophysiology Laboratory at Christian Medical College, Ludhiana, India, between January 1990 to December 2003. There were 36 (55%) patients with sciatic nerve palsy, 29 (44%) patients with radial nerve injury, and 1 (1%) patient with posterior femoral cutaneous nerve injury. In 57 (86%) patients, the IMI were given by uncertified medical practitioners. Needle electromyography (EMG) was analyzed in 36 patients (>or=60 days after onset). In 12 (33%) patients, there was EMG evidence of axonal damage with reinnervation, while in the other 24 (67%) patients, there was axonal damage without reinnervation. Only 18 (28%) patients had a good recovery. In conclusion, NI following IMI is a preventable iatrogenic hazard, which carries a poor prognosis.

Only 40·9% of the patients returned to driving or riding. Lower education, unemployment, and poor recovery were the predictors of inability to drive or ride. Inability to drive had a major impact in their social life.

Strongyloides stercoralis (SS) is one of the most overlooked helminthic infections despite being highly endemic in tropical and subtropical areas. In immunocompromised patients, especially those on long-term steroids, infection can often escalate to fatal dissemination into major organs. We present a compendium of two immunocompromised patients, who were on high-dose steroids and presented with worsening neurological status. Cerebrospinal fluid analysis was notable for larvae of SS as diagnosed by direct visualization. A syndrome of SS hyperinfection with dissemination was made after stool, and sputum samples also revealed SS larvae. SS is an elusive disease and should be considered early on, especially in endemic regions like India. Early diagnosis and prompt initiation of antihelminthic therapy is indispensable for favorable outcomes.

Introduction/Aims: Understanding the potential causes and consequences of diagnostic delay in Guillain-Barré syndrome (GBS) could improve quality of care and outcomes. We aimed to determine these causes and consequences in our cohort of patients with GBS.Methods: We retrospectively reviewed records of subjects with GBS, admitted to our center at University Hospitals Birmingham, UK, between January 2005 and December 2020. We evaluated time to diagnosis from presentation, factors associated with diagnostic delay, and its potential consequences. Results: We included 119 consecutive subjects. Diagnostic delay at least 5 days from first presentation occurred in 27 of 119 (22.7%) of patients. Diagnostic delay was associated with age >60 years (odds ratio [OR], 3.58; 95% confidence interval [CI],